Humaid Al-Shamsi, Chief Executive Officer at Burjeel Cancer Institute and Regional Director of Burjeel Oncology GCC at Burjeel Holdings, shared a post on LinkedIn about a paper he co-authored with colleagues published in Cancers:
“Proud to share my 17th publication of 2025 and the 175th of my academic and scientific career.
This is the first study from the United Arab Emirates on the therapeutic use of CAR-T cell therapies in cancer treatment. Our work sheds light on the latest advancements and challenges in applying CAR-T therapies to solid tumors, including lung, colorectal, gastric, uterine, and breast cancers.
I am grateful to my colleagues from Saudi Arabia and India for their valuable contributions to this collaborative effort.”
Title: Advancing CAR T-Cell Therapy in Solid Tumors: Current Landscape and Future Directions
Authors: Saeed Rafii, Deborah Mukherji, Ashok Sebastian Komaranchath, Charbel Khalil, Faryal Iqbal, Siddig Ibrahim Abdelwahab, Amin Abyad, Ahmad Y. Abuhelwa, Lakshmikanth Gandikota, Humaid O. Al-Shamsi
You can read the Full Article in Cancers.
More posts featuring Humaid Al-Shamsi.